Literature DB >> 2029909

N-acetylglucosaminono-1,5-lactone oxime and the corresponding (phenylcarbamoyl)oxime. Novel and potent inhibitors of beta-N-acetylglucosaminidase.

M Horsch1, L Hoesch, A Vasella, D M Rast.   

Abstract

Using N-acetylglucosaminono-1,5-lactone (1) as the reference, the inhibitory activity of its (formal) derivatives N-acetylglucosaminono-1,5-lactone oxime (2) and N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)-oxime (3) was tested against beta-N-acetylglucosaminidase of different origins (animal, plant, fungus). Displaying inhibition constants of 0.45 microM and 0.62 microM, for the animal and plant enzyme, respectively, the simple oxime 2 was about equally potent as the parent lactone 1, and 50-400 times more efficient than two recently described new beta-N-acetylglucosaminidase inhibitors. The (phenylcarbamoyl)oxime 3 performed even better, particularly with the fungal enzyme (Ki = 40 nM), i.e. was about 350 times more potent than the lactone. In all cases competitive inhibition was observed with 4-nitrophenyl-beta-N-acetylglucosaminide as the substrate. With Ki/Km ratios up to 3300 for 2 and 13,600 for 3, the mode of action of these novel inhibitors is probably that of transition state mimicry. Suggestions are made for their use as a tool in biological research.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029909     DOI: 10.1111/j.1432-1033.1991.tb15976.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  31 in total

1.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.

Authors:  John C Chatham; Richard B Marchase
Journal:  Curr Signal Transduct Ther       Date:  2010-01

2.  Mammalian cells contain a second nucleocytoplasmic hexosaminidase.

Authors:  Martin Gutternigg; Dubravko Rendić; Regina Voglauer; Thomas Iskratsch; Iain B H Wilson
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

3.  GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels.

Authors:  Helge C Dorfmueller; Vladimir S Borodkin; Marianne Schimpl; Sharon M Shepherd; Natalia A Shpiro; Daan M F van Aalten
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

4.  Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.

Authors:  Johanna C Gandy; Abigail E Rountree; Gautam N Bijur
Journal:  FEBS Lett       Date:  2006-04-27       Impact factor: 4.124

5.  Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.

Authors:  Stephen A Whelan; Wagner B Dias; Lakshmanan Thiruneelakantapillai; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

6.  Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway flux.

Authors:  Leighton R James; Catherine Le; James W Scholey
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-10       Impact factor: 4.310

Review 7.  The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses.

Authors:  John C Chatham; Richard B Marchase
Journal:  Biochim Biophys Acta       Date:  2009-07-14

Review 8.  Glycosidase inhibition: assessing mimicry of the transition state.

Authors:  Tracey M Gloster; Gideon J Davies
Journal:  Org Biomol Chem       Date:  2009-11-05       Impact factor: 3.876

9.  Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds.

Authors:  Helge C Dorfmueller; Daan M F van Aalten
Journal:  FEBS Lett       Date:  2009-12-16       Impact factor: 4.124

10.  Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes.

Authors:  Matthew S Macauley; Yuan He; Tracey M Gloster; Keith A Stubbs; Gideon J Davies; David J Vocadlo
Journal:  Chem Biol       Date:  2010-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.